Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.13 μM and 0.015 μM for Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS) and Plasmodium falciparum lysyl-tRNA synthetase (PfKRS), respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,070.00 | |
50 mg | 6-8 weeks | $ 1,390.00 | |
100 mg | 6-8 weeks | $ 2,090.00 |
Description | LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.13 μM and 0.015 μM for Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS) and Plasmodium falciparum lysyl-tRNA synthetase (PfKRS), respectively. |
Targets&IC50 | PfKRS:0.015 μM , CpKRS:0.13 μM |
In vitro | LysRs-IN-2 is active against whole-cell bloodstream P. falciparum 3D7 (EC50=0.27 μM),HepG2 cells (EC50=49 μM) , HsKRS (IC50=1.8 μM), and Cryptosporidium parvum (EC50=2.5 μM)[1]. |
In vivo | LysRs-IN-2 (20 mg/kg; orally once a day for 7 days) reduces parasite shedding in NOD SCID gamma mice and INF-γ-knockout mice (Cryptosporidium mouse models)[1].LysRs-IN-2 (1.5 mg/kg; orally once a day for 4 days) reduces parasitemia by 90% in the murine P. falciparum SCID model. |
Molecular Weight | 355.31 |
Formula | C17H16F3NO4 |
CAS No. | 2170696-76-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (168.87 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LysRs-IN-2 2170696-76-9 Others LysRsIN2 LysRs IN 2 inhibitor inhibit